Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

Eija Korkeila,T. Salminen,Raija Kallio,M Mikkola,P. Auvinen,Seppo Pyrhönen,Raija Ristamäki

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

2017

Eija Korkeila
T. Salminen
Raija Kallio
M Mikkola
P. Auvinen
Seppo Pyrhönen
Raija Ristamäki

Purpose This study aimed to evaluate the feasibility and tolerability of biweekly docetaxel with capecitabine as first-line treatment in advanced gastro-oesophageal cancer.

Keywords:

Intensive care medicine
Capecitabine
Physical therapy
Cancer
Gastro-
Medicine
Chemotherapy
Docetaxel
Tolerability
Internal medicine
Quality of life
Prospective cohort study
Oncology
gastro oesophageal cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations